Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExcellGene
Monthey, Valais, Switzerlandexcellgene.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ExcellGene has established itself as a leading Swiss biologics CDMO with deep expertise in challenging protein expression using mammalian and insect cell systems. The company’s proprietary platforms enable rapid development from DNA to product. It has supported hundreds of clients globally—including top pharmaceutical companies—in advancing their biologic drug candidates from concept through to clinic. Its technologies are widely licensed by industry partners. Patent activity includes vaccine compositions against viral diseases like Ebola.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Recombinant proteins (including antibodies, fusion molecules, hormones)Virus vectors (AAV)Biosimilars
- Industry
- Contract Manufacturing Organization
02
Partnerships
Hundreds of biotech/pharma clients worldwide (including six of the top ten pharmaceutical firms)
Beyond the preview
Go deeper on ExcellGene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExcellGene.